❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ News ❭

News

Scroll to top

Home Institute for Cancer Research Dept. of Tumor Biology

  • Resources and expertise
  • Kjersti Flatmark's group
  • Eivind Hovig's group
  • Jørgen Wesche's group
  • G. Mælandsmo's group
  • Project groups Tumor Biology
  • Publications
  • Staff
  • Vacant positions
  • News

Recent publications

Bjørnerud B, Wesche J, Haugsten EM (2025)
A rhabdomyosarcoma cell migration inhibitor screen using phase-contrast microscopy
Exp Cell Res, 114582 (in press)
DOI 10.1016/j.yexcr.2025.114582, PubMed 40320199

Torices L, Nunes-Xavier CE, Pulido R (2025)
Therapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons From Tumor Suppressor Genes
IUBMB Life, 77 (5), e70018
DOI 10.1002/iub.70018, PubMed 40317855

Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)